US3808233A - Zearalenone reduction - Google Patents
Zearalenone reduction Download PDFInfo
- Publication number
- US3808233A US3808233A US00292449A US29244972A US3808233A US 3808233 A US3808233 A US 3808233A US 00292449 A US00292449 A US 00292449A US 29244972 A US29244972 A US 29244972A US 3808233 A US3808233 A US 3808233A
- Authority
- US
- United States
- Prior art keywords
- zearalenone
- acid
- zearalanol
- reduction
- diastereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03F—AMPLIFIERS
- H03F1/00—Details of amplifiers with only discharge tubes, only semiconductor devices or only unspecified devices as amplifying elements
- H03F1/02—Modifications of amplifiers to raise the efficiency, e.g. gliding Class A stages, use of an auxiliary oscillation
-
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03F—AMPLIFIERS
- H03F3/00—Amplifiers with only discharge tubes or only semiconductor devices as amplifying elements
- H03F3/20—Power amplifiers, e.g. Class B amplifiers, Class C amplifiers
- H03F3/24—Power amplifiers, e.g. Class B amplifiers, Class C amplifiers of transmitter output stages
Definitions
- Zearalenone is catalytically reduced with hydrogen for a time suflicient to reduce the zearalenone to zearalanol in the presence of a platinum catalyst and a weak acid having a first acid ionization constant of from about 1X10 to X in water at about 25 C. and said acid not being itself reduced under the conditions of the zearalenone reduction.
- This invention relates to a method for reducing zearalenone to a mixture of the highand low-melting point diastereoisomers of zearalanol.
- zearalenone and zearalanol conform with the nomenclature in an article in Tetrahedron Letters, Pergamon Press, Ltd., No. 27, pp. 3109-3114 (1966).
- zearalenone having the formula is converted to zearalanol, having the formula r n)a (CHM by reduction of the olefinic bond and the ketone group in the presence of hydrogen, a mixture of diastereoisomers of zearalanol is formed.
- This reduction carried out in the presence of a Raney nickel catalyst, is disclosed in U.S. Pat. No. 3,239,345.
- the diastereoisomers differ in melting point.
- the disclosed reduction provides an approximately 55:45 ratio of the high-melting point to the lowmelting point diastereoisomer.
- certain weak acids may be employed in a process for the catalytic reduction of zearalenone to a mixture containing a major amount, e.g., greater than weight percent, for example, about weight percent or more, of the diastereoisomer of zearalanol having the higher melting point and a minor amount, e.g., less than 45 weight percent, for example, about 40 weight percent or less, of the diasteroisomer of zearalanol having the lower melting point.
- a major amount e.g., greater than weight percent, for example, about weight percent or more
- zearalanol having the higher melting point e.g., about weight percent or more
- a minor amount e.g., less than 45 weight percent, for example, about 40 weight percent or less
- the reduction of zearalenone is conducted in the presence of a solvent, a platinum catalyst, and certain weak acids for a time sufiicient to reduce the zearalenone to zearalanol and provide a high ratio of the high melting point diastereoisomer to the low melting point diastereoisomer.
- the product will generally contain a major amount of the high melting point diastereoisomer of zearalanol.
- the weak acid employed in the process of the present invention has a first acid ionization constant of from about 1X10- preferably 5X10- to 5 X 10- in an aqueous solution at 25 C., and will not itself be reduced to a weaker acid under the conditions employed for the zearalenone reduction.
- weak acid refers to acids which are less than essentially completely ionized in water (except in extremely dilute solution). It conforms with standard nomenclature as found in, for example, Fundamental Concepts of Chemistry, Appleton-Century-Crofts (1969), pp. 233 and 234. Such weak acids include weak acids as well as moderately strong acids. Exemplary of the weak acids which may be employed in the present invention are citric acid, tartaric acid, phosphoric acid, and oxalic acid.
- the zearalenone can be prepared and purified as described in Examples II and III of U.S. Pat. No. 3,239,345.
- the zearalenone is advantageously suspended or dissolved in a suitable solvent, preferably a lower alkanol, e.g., ethanol, normal propyl alcohol, isopropyl alcohol and the I like, preferably those containing from 1 to 3 carbon atoms and particularly ethanol.
- zearalanol-producing amounts of a weak acid often a small amount, e.g., about 0.001 to 5 volume percent (based on the solvent), preferably from about 0.01 to 3 volume percent or equivalent weight, of weak acid is added to the solvent.
- the reaction may be conducted in the presence of, for instance, about 2 to 10 volume percent of water.
- the zearalenone and solvent can advantageously be present in amounts of, for example, from about 1 to 25 grams of zearalenone per cc. of the solvent.
- a platinum catalyst supported on a suitable carrier, e.g., charcoal, is advantageously used.
- the catalyst contains from about 0.01 to about 10 weight percent of platinum and is employed in catalytic amounts, generally a catalyst to zearalenone weight ratio of from about 0.00l:1 to 1:1.
- the zearalenone is reduced in the presence of hydrogen under reducing conditions for a time suflicient to reduce substantially all of the zearalenone.
- the reduction can be carried out at a temperature of from about 15 to 100 C., preferably about 20 to 60 C. with a hydrogen pressure generally of from about 20 to 1000 p.s.i., preferably 25 to 100 p.s.i., for at least 3, preferably about 3 to 8, hours.
- the platinum catalyst is removed from the reaction mixture, e.g., by filtration, andthe resulting'mixture can; as a-matter of convenience, be concentrated, to say, a volume of from about 0.5 to 0.1 of the reaction mixture volume, and filtered again.
- the filtered, concentrated solution can be diisomer of zearalanol comprising catalytically reducing luted with-water, for example, in an amount of from zearalenone with hydrogen under reducing conditions in about 2 to 4 volumes of the concentrated solution, by addthe presence of zearalanol-producing amounts of a weak ing water slowly while stirring the solution.
- said weak solution is advantageously allowed to stand at room temacid having a first acid ionization constant of from about perature for a time suflicient to allow the zearalanol to 1 10 to 5 10- in aqueous solution and said weak precipitate from the solution which can be about 2 to 4 acid not itself being reduced to a weaker acid under the hours or more. Filtration of the mixture yields the white reducing conditions.
- the catalyst is employed in a catalyst to zearalenone weight
- the following examples are presented to further illusratio from about 0.001:1 to 1:1. trate the invention and are not in limitation thereof.
- zearalanol which is analyzed to be about 76% of the hlgh 7
- EXAMPLES H t 1X 8 The method of claim 1 wherein the weak acid has The following examples were conducted in essentially a first acid ionization constant of from about 5 1O to the same procedure as that set forth in Example 1 except 5X 10-1- ditferent solvents and weak acids are employed. The re- 9. The method of claim 2 wherein the weak acid is sults of these examples are set forth in Table I. 40 tartaric acid.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Power Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A METHOD FOR REDUCING ZEARALINONE TO ZERALANOL IN WHICH THE PRODUCT CONTAINS A MAJOR AMOUNT OF THE HIGHMELTING DIASTEREOISOMER AND A MINOR AMOUNT OF THE LOWMELTING DIASTEREOISOMER OF ZEARALANOL IS DISCLOSED. ZEARALENONE IS CATALYTICALLY REDUCED WITH HYDROGEN FOR A TIME SUFFICIENT TO REDUCE THE ZEARALENONE TO ZEARALANOL IN THE PRESENCE OF A PLATINUM CATALYST AND A WEAK ACID HAVING A FIRST ACID IONIZATION CONSTANT OF FROM ABOUT 1X10**4 TO 5X10**1 IN WATER AT ABOUT 25:C. AND SAID ACID NOT BEING ITSELF REDUCED UNDER THE CONDITIONS OF THE ZEARALENONE REDUCTION.
Description
United States Patent 3,808,233 ZEARALENONE REDUCTION Edward B. Hodge, Terre Haute, Ind., assignor to Commercial Solvents Corporation, Terre Haute, Ind. No Drawing. Filed Sept. 26, 1972, Ser. No. 292,449 Int. Cl. C07d 9/00 U.S. Cl. 260-343.2 F 12 Claims ABSTRACT OF THE DISCLOSURE A method for reducing zearalenone to zearalanol in which the product contains a major amount of the highmelting diastereoisomer and a minor amount of the lowmelting diastereoisomer of zearalanol is disclosed. Zearalenone is catalytically reduced with hydrogen for a time suflicient to reduce the zearalenone to zearalanol in the presence of a platinum catalyst and a weak acid having a first acid ionization constant of from about 1X10 to X in water at about 25 C. and said acid not being itself reduced under the conditions of the zearalenone reduction.
This invention relates to a method for reducing zearalenone to a mixture of the highand low-melting point diastereoisomers of zearalanol.
The terms zearalenone and zearalanol conform with the nomenclature in an article in Tetrahedron Letters, Pergamon Press, Ltd., No. 27, pp. 3109-3114 (1966). When zearalenone, having the formula is converted to zearalanol, having the formula r n)a (CHM by reduction of the olefinic bond and the ketone group in the presence of hydrogen, a mixture of diastereoisomers of zearalanol is formed. This reduction, carried out in the presence of a Raney nickel catalyst, is disclosed in U.S. Pat. No. 3,239,345. The diastereoisomers differ in melting point. The disclosed reduction provides an approximately 55:45 ratio of the high-melting point to the lowmelting point diastereoisomer.
Disclosed in U.S. Patent application Ser. No. 25,265, filed Apr. 2, 1970, now U.S. Pat. 3,697,548, and in corresponding Belgium Pat. No. 765,130, is a method of catalytically reducing zearalenone to a mixture containing a major amount of the diastereoisomer of zearalanol having the higher melting point and a minor amount of diastereoisomer of zearalanol having the lower melting point in the presence of a strong acid, that is, an acid which is essentially completely ionized in an aqueous solution. This process, while producing a good conversion of zearalenone to the diasteroisomer of zearalanol having the higher melting point with a relatively rapid rate of conversion, requires reaction vessels which are extremely resistant to strong acids or requires frequent replacement of reaction vessels due to corrosion.
It was also disclosed in United States patent application Ser. No. 25,265, now U.S. Pat. No. 3,697,548, and corresponding Belgium Pat. No. 765,130, that a weak acid, e.g., acetic acid, was found unsatisfactory for promoting the reduction of zearalenone to the high boiling diastero- 3,808,233 Patented Apr. 30, 1974 isomer of zearalanol. For example, acetic acid only provides about a 15 to 20 percent reduction of zearalenone to zearalanol after a six hour reaction period.
The product can be separated utilizing a procedure disclosed in Examples I and II of U.S. Pat. No. 3,574,235 in the name of Vernon V. Young. Both diasteroisomers of zearalanol are useful as anabolic substances for oral and parenteral administration to animals in the manner disclosed in U.S. Pat. No. 3,239,345.
It has now been found that certain weak acids may be employed in a process for the catalytic reduction of zearalenone to a mixture containing a major amount, e.g., greater than weight percent, for example, about weight percent or more, of the diastereoisomer of zearalanol having the higher melting point and a minor amount, e.g., less than 45 weight percent, for example, about 40 weight percent or less, of the diasteroisomer of zearalanol having the lower melting point.
In accordance with the present invention, the reduction of zearalenone is conducted in the presence of a solvent, a platinum catalyst, and certain weak acids for a time sufiicient to reduce the zearalenone to zearalanol and provide a high ratio of the high melting point diastereoisomer to the low melting point diastereoisomer. The product will generally contain a major amount of the high melting point diastereoisomer of zearalanol. The weak acid employed in the process of the present invention has a first acid ionization constant of from about 1X10- preferably 5X10- to 5 X 10- in an aqueous solution at 25 C., and will not itself be reduced to a weaker acid under the conditions employed for the zearalenone reduction.
The term weak acid, as used herein, refers to acids which are less than essentially completely ionized in water (except in extremely dilute solution). It conforms with standard nomenclature as found in, for example, Fundamental Concepts of Chemistry, Appleton-Century-Crofts (1969), pp. 233 and 234. Such weak acids include weak acids as well as moderately strong acids. Exemplary of the weak acids which may be employed in the present invention are citric acid, tartaric acid, phosphoric acid, and oxalic acid.
The zearalenone can be prepared and purified as described in Examples II and III of U.S. Pat. No. 3,239,345. The zearalenone is advantageously suspended or dissolved in a suitable solvent, preferably a lower alkanol, e.g., ethanol, normal propyl alcohol, isopropyl alcohol and the I like, preferably those containing from 1 to 3 carbon atoms and particularly ethanol. zearalanol-producing amounts of a weak acid, often a small amount, e.g., about 0.001 to 5 volume percent (based on the solvent), preferably from about 0.01 to 3 volume percent or equivalent weight, of weak acid is added to the solvent. The reaction may be conducted in the presence of, for instance, about 2 to 10 volume percent of water.
The zearalenone and solvent can advantageously be present in amounts of, for example, from about 1 to 25 grams of zearalenone per cc. of the solvent. A platinum catalyst supported on a suitable carrier, e.g., charcoal, is advantageously used. Generally, the catalyst contains from about 0.01 to about 10 weight percent of platinum and is employed in catalytic amounts, generally a catalyst to zearalenone weight ratio of from about 0.00l:1 to 1:1.
The zearalenone is reduced in the presence of hydrogen under reducing conditions for a time suflicient to reduce substantially all of the zearalenone. Advantageously, the reduction can be carried out at a temperature of from about 15 to 100 C., preferably about 20 to 60 C. with a hydrogen pressure generally of from about 20 to 1000 p.s.i., preferably 25 to 100 p.s.i., for at least 3, preferably about 3 to 8, hours. After the reduction, the platinum catalyst is removed from the reaction mixture, e.g., by filtration, andthe resulting'mixture can; as a-matter of convenience, be concentrated, to say, a volume of from about 0.5 to 0.1 of the reaction mixture volume, and filtered again. The filtered, concentrated solution can be diisomer of zearalanol comprising catalytically reducing luted with-water, for example, in an amount of from zearalenone with hydrogen under reducing conditions in about 2 to 4 volumes of the concentrated solution, by addthe presence of zearalanol-producing amounts of a weak ing water slowly while stirring the solution. The resulting acid and catalytic amounts of platinum catalyst, said weak solution is advantageously allowed to stand at room temacid having a first acid ionization constant of from about perature for a time suflicient to allow the zearalanol to 1 10 to 5 10- in aqueous solution and said weak precipitate from the solution which can be about 2 to 4 acid not itself being reduced to a weaker acid under the hours or more. Filtration of the mixture yields the white reducing conditions.
crystals of zearalanol containing a major amount of the 2. The method of claim 1 wherein the reducing conhigh melting diastereoisomer and a minor amount of the ditions include temperatures from about to 100 C. low melting diastereoisomer which can be separated as 15 and a hydrogen pressure from about to 1000 p.s.i. and noted above. the catalyst is employed in a catalyst to zearalenone weight The following examples are presented to further illusratio from about 0.001:1 to 1:1. trate the invention and are not in limitation thereof. 3. The method of claim 2 wherein the reduction is con- EXAMPLE I ducted in the presence of a solvent consisting essentially 20 of a lower alkanol solvent.
Three grams (g) of zearalenone and 3 milliliters of 4. The method of claim 3 wherein the lower alkanol 85% phosphoric acid are added to 200 ml. of ethanol at contains from 1 to 3 carbon atoms and the solvent conroom temperature, after flushlflg With nitrogen, tains from about 0.001 to 5 volume percent (based on g. of a 5 percent platinum on charcoal catalyst is added. the l f h weak i The solutlon charged mm an Adams reducmg P 5. The method of claim 2 wherein the catalytic reacratus and g g hydrogen for 6 hours i room tion is carried out with reducing conditions including temperature un era y rogen pressure of p.s.1. The resultperatures from about 20 to and a hydrogen Pres mg reduced mlxture 1S filtered, concentrated to ml. Sure from about 25 to Si nd filtered again. Then 400 ml of water are added to a 6. The method of claim 3 wherein the solvent conthe mixture slowly w1th stirring. After 3 hours at room 30 ak f b 1 temperature the mixture is filtered to give 2 61 g of tams we an m an amount mm a out to 3 V0- ume percent, based on the volume of the solvent. zearalanol which is analyzed to be about 76% of the hlgh 7 The method of claim 2 wherein the reduction is com melting diastereoisomer and 24% of the low melting diastereoisomer ducted 1n the presence of water in an amount of about 2 5 to 10 volume percent.
EXAMPLES H t 1X 8. The method of claim 1 wherein the weak acid has The following examples were conducted in essentially a first acid ionization constant of from about 5 1O to the same procedure as that set forth in Example 1 except 5X 10-1- ditferent solvents and weak acids are employed. The re- 9. The method of claim 2 wherein the weak acid is sults of these examples are set forth in Table I. 40 tartaric acid.
TABLE I Amount zearalanol recovered Ratio of high Amt Time iit ir ei 57 33251251? Example Solvent Weak acid hrs. charged e perceni'.
II; Ethanol Tartaric 2 7 III- d d 2 8 IV. Isopropanol ..do 2 7 V t-Bntanol Phosphoric-- 2 7 VI Ethanol Oxalic 2 7 VII nn cum- 2 7 VIIL; do Succinic"--- 2 7 IX do Maleic 2 7 1 Product obtained in mostly zearalanone the results obtained are comparable to that of Example 65 VIH.
10. The method of claim 2 wherein the weak acid is phosphoric acid.
11. The method of claim 2 wherein the weak acid is oxalic acid..
12. The method of claim 2 wherein the weak acid is citric acid.
References Cited UNITED STATES PATENTS 3,687,982 8/1972 Young 260343.2 3,697,548 10/1972 Hodge 260343.2
JOHN M. FORD, Primary Examiner
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00292449A US3808233A (en) | 1972-09-26 | 1972-09-26 | Zearalenone reduction |
DE2328605A DE2328605C2 (en) | 1972-09-26 | 1973-06-05 | Process for the preparation of a mixture of diastereoisomers of zearalanol |
CA173,325A CA980785A (en) | 1972-09-26 | 1973-06-06 | Zearalenone reduction |
AT511973A AT330377B (en) | 1972-09-26 | 1973-06-12 | PROCESS FOR PREPARING A DIASTEREOISOMER MIXTURE OF ZEARALANOL |
ZA734356A ZA734356B (en) | 1972-09-26 | 1973-06-26 | Zearalenone reduction |
IL42623A IL42623A (en) | 1972-09-26 | 1973-06-28 | Reduction of zearalenone |
AU57512/73A AU475426B2 (en) | 1972-09-26 | 1973-06-29 | Zearalenone reduction |
GB3149073A GB1379859A (en) | 1972-09-26 | 1973-07-02 | Zearalenone reduction |
CH978473A CH587839A5 (en) | 1972-09-26 | 1973-07-05 | |
ES417199A ES417199A1 (en) | 1972-09-26 | 1973-07-10 | Zearalenone reduction |
DK394573AA DK130464B (en) | 1972-09-26 | 1973-07-17 | Process for reducing zearalenone to zearalanol. |
PH14833A PH10914A (en) | 1972-09-26 | 1973-07-18 | Zearalenone reduction |
SE7310661A SE383745B (en) | 1972-09-26 | 1973-08-02 | WAY TO REDUCE ZEARALENONE TO A DIASTEREOISOMER MIXTURE OF ZEARALANOL |
NL7311613A NL7311613A (en) | 1972-09-26 | 1973-08-23 | |
BE135997A BE805261A (en) | 1972-09-26 | 1973-09-25 | ZEARALENONE REDUCTION |
FR7334287A FR2200263B1 (en) | 1972-09-26 | 1973-09-25 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00292449A US3808233A (en) | 1972-09-26 | 1972-09-26 | Zearalenone reduction |
Publications (1)
Publication Number | Publication Date |
---|---|
US3808233A true US3808233A (en) | 1974-04-30 |
Family
ID=23124719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00292449A Expired - Lifetime US3808233A (en) | 1972-09-26 | 1972-09-26 | Zearalenone reduction |
Country Status (16)
Country | Link |
---|---|
US (1) | US3808233A (en) |
AT (1) | AT330377B (en) |
AU (1) | AU475426B2 (en) |
BE (1) | BE805261A (en) |
CA (1) | CA980785A (en) |
CH (1) | CH587839A5 (en) |
DE (1) | DE2328605C2 (en) |
DK (1) | DK130464B (en) |
ES (1) | ES417199A1 (en) |
FR (1) | FR2200263B1 (en) |
GB (1) | GB1379859A (en) |
IL (1) | IL42623A (en) |
NL (1) | NL7311613A (en) |
PH (1) | PH10914A (en) |
SE (1) | SE383745B (en) |
ZA (1) | ZA734356B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8674120B2 (en) | 2009-04-09 | 2014-03-18 | Intervet International B.V. | Process for manufacturing zeranol |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3697548A (en) * | 1970-04-02 | 1972-10-10 | Commercial Solvents Corp | Zearalenone reduction |
-
1972
- 1972-09-26 US US00292449A patent/US3808233A/en not_active Expired - Lifetime
-
1973
- 1973-06-05 DE DE2328605A patent/DE2328605C2/en not_active Expired
- 1973-06-06 CA CA173,325A patent/CA980785A/en not_active Expired
- 1973-06-12 AT AT511973A patent/AT330377B/en not_active IP Right Cessation
- 1973-06-26 ZA ZA734356A patent/ZA734356B/en unknown
- 1973-06-28 IL IL42623A patent/IL42623A/en unknown
- 1973-06-29 AU AU57512/73A patent/AU475426B2/en not_active Expired
- 1973-07-02 GB GB3149073A patent/GB1379859A/en not_active Expired
- 1973-07-05 CH CH978473A patent/CH587839A5/xx not_active IP Right Cessation
- 1973-07-10 ES ES417199A patent/ES417199A1/en not_active Expired
- 1973-07-17 DK DK394573AA patent/DK130464B/en not_active IP Right Cessation
- 1973-07-18 PH PH14833A patent/PH10914A/en unknown
- 1973-08-02 SE SE7310661A patent/SE383745B/en unknown
- 1973-08-23 NL NL7311613A patent/NL7311613A/xx not_active Application Discontinuation
- 1973-09-25 BE BE135997A patent/BE805261A/en not_active IP Right Cessation
- 1973-09-25 FR FR7334287A patent/FR2200263B1/fr not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8674120B2 (en) | 2009-04-09 | 2014-03-18 | Intervet International B.V. | Process for manufacturing zeranol |
Also Published As
Publication number | Publication date |
---|---|
DK130464C (en) | 1975-07-21 |
DE2328605C2 (en) | 1986-07-10 |
CH587839A5 (en) | 1977-05-13 |
ZA734356B (en) | 1974-06-26 |
BE805261A (en) | 1974-01-16 |
DK130464B (en) | 1975-02-24 |
FR2200263B1 (en) | 1978-11-10 |
GB1379859A (en) | 1975-01-08 |
IL42623A (en) | 1976-08-31 |
IL42623A0 (en) | 1973-08-29 |
ES417199A1 (en) | 1976-06-01 |
SE383745B (en) | 1976-03-29 |
NL7311613A (en) | 1974-03-28 |
DE2328605A1 (en) | 1974-04-04 |
AT330377B (en) | 1976-06-25 |
ATA511973A (en) | 1975-09-15 |
AU5751273A (en) | 1975-01-09 |
AU475426B2 (en) | 1976-08-19 |
CA980785A (en) | 1975-12-30 |
PH10914A (en) | 1977-10-04 |
FR2200263A1 (en) | 1974-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nickon et al. | Configuration of tropine and pseudotropine | |
Pickard et al. | Ketimines. I. Alkyl-Aryl Type1 | |
US3950405A (en) | Trans-4-aminomethylcyclohexane-1-carboxylic acid | |
US3808233A (en) | Zearalenone reduction | |
Rapoport et al. | Stereochemical Studies in the Morphine Series. The Relative Configuration at Carbons Thirteen and Fourteen1 | |
Aasen et al. | Saturated pyrrolizidinediols. II. Total synthesis and stereochemistry of macronecine | |
DE2139516B2 (en) | 3,4-DIHYDROXYBENZYL ALCOHOL DERIVATIVES, THEIR ACID-ADDITIONAL SALTS, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS | |
DE1620381A1 (en) | Derivatives of 2-aminopyrazine and process for their preparation | |
US3704248A (en) | Zearalenone reduction | |
DE1793693C3 (en) | ||
US2927112A (en) | 3-amino-6-halopyridazines and process of preparation | |
US3697548A (en) | Zearalenone reduction | |
DE1161273B (en) | Process for the preparation of N-substituted 3-oxypyrrolidinobenzilic acid esters. | |
US3141015A (en) | Hgmopiperazinoalkyl estess | |
US3520921A (en) | Preparation of cis-hexahydrophthalic acid from phthalic acid | |
US3742063A (en) | Dihydroxybutanones | |
US2351302A (en) | Production of methyl glycerol | |
US2982774A (en) | 21-aldehydes of 9alpha-fluoro-steroids and derivatives thereof | |
US3472736A (en) | Process for making delta**4-conenine-11 alpha-ol-3-one | |
DE937953C (en) | Process for the preparation of 2-aminoindan compounds with analeptic activity | |
DE895595C (en) | Process for the preparation of aminoalkynols | |
US2786850A (en) | Method of preparing 5-(delta-chlorobutyl) hydantoin | |
US2786849A (en) | Production of 5-(delta-hydroxybutyl) hydantoin | |
US3084158A (en) | 11beta, 18-oxido-18zata-methyl-progesterone | |
Richmond et al. | The Ozonolysis of Substituted Maleic Acid Imides and its Application to the Degradation of Porphyrins1 |